Kestra Private Wealth Services, LLC Vaxart, Inc. Transaction History

Kestra Private Wealth Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$0.69 - $0.85 $16,560 - $20,400	24,000 New	24,000 $18,000
Q4 2022 Jan 31, 2023	SELL	$0.75 - $2.24 $750 - $2,240	-1,000 Reduced 9.09%	10,000 $9,000
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $64,789 - $139,500	-31,000 Reduced 73.81%	11,000 $24,000
Q1 2022 May 26, 2022	SELL	$4.29 - $6.64 $17,160 - $26,560	-4,000 Reduced 8.7%	42,000 $211,000
Q4 2021 Jan 21, 2022	BUY	$5.77 - $7.96 $190,410 - $262,680	33,000 Added 253.85%	46,000 $288,000
Q1 2021 May 11, 2021	BUY	$5.64 - $23.33 $73,320 - $303,290	13,000 New	13,000 $78,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.